NCT00031642View on ClinicalTrials.gov

Monoclonal Antibody Therapy in Relapsed Non-Hodgkin's After Chemotherapy and Autologous Stem Cell Transplantation

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 1, 2002

Primary Completion Date

November 1, 2005

Study Completion Date

March 1, 2008

Conditions
Lymphoma
Interventions
BIOLOGICAL

rituximab

RADIATION

yttrium Y 90 ibritumomab tiuxetan

Trial Locations (1)

68198-7680

Eppley Cancer Center at University of Nebraska Medical Center, Omaha

Sponsors

Collaborators (1)

Biogen
All Listed Sponsors
collaborator

Biogen

INDUSTRY

lead

University of Nebraska

OTHER